Skip to main content
. Author manuscript; available in PMC: 2010 Feb 1.
Published in final edited form as: Clin Cancer Res. 2009 Feb 1;15(3):986–994. doi: 10.1158/1078-0432.CCR-08-1287

Table 1.

Summary of patient information

Patient
No.
Sex Age Primary Site Tumor
Staging
Concurrent
systemic
therapy
Post-Tx
Surgery
Pathology 6-month
follow-up
1 M 51 vallecula T2N2cM0 chemo Y positive DM*
2 M 76 tonsil TxN2bM0 chemo Y positive DM
3 M 75 base of tongue T4N2cM0 chemo Y negative NED**
4 M 42 tonsil T2N2bM0 chemo Y negative NED
5 F 53 tonsil TxN2bM0 chemo Y negative NED
6 M 50 base of tongue T2N2aM0 chemo Y negative NED
7 M 58 base of tongue T3N2cM0 chemo Y negative NED
8 M 76 larynx T2N2bM0 chemo Y positive NED
9 M 56 larynx T2N3M0 chemo Y positive DM
10 M 31 larynx T4aN2bM0 chemo N NED
11 M 72 unknown primary TxN2bM0 chemo N NED
12 F 78 unknown primary T4aN2bM0 immuno N NED
13 F 68 base of tongue T4N2bM0 chemo N DM
14 M 49 tonsil T3N2aM0 immuno Y negative NED
15 M 61 base of tongue T3N2aM0 immuno Y negative NED
16 M 51 base of tongue TxN2bM0 chemo Y negative NED
17 M 64 unknown primary TxN3M0 chemo Y positive DM
18 M 55 tonsil T3N2bM0 chemo Y negative NED
19 M 60 tonsil T4N1M0 chemo Y positve NED
20 F 55 larynx T3N2cM0 chemo Y negative NED
21 F 62 tonsil T2N2cM0 chemo Y negative NED
22 M 65 unknown primary TxN2bM0 chemo Y negative NED
23 M 63 larynx T2N2bM0 chemo Y positve NED
24 F 48 tonsil T4bN2bM0 immuno N Relapse
25 M 72 base of tongue T4N2cM0 immuno N NED
26 F 61 larynx TxN2aM0 chemo Y negative NED
27 M 67 unknown primary T0N2bM0 immuno N NED
28 M 52 base of tongue T1N2abM0 chemo Y negative NED
29 M 67 tonsil T2N2bM0 chemo N NED
30 M 70 tonsil T4N1aM0 chemo N NED
31 M 67 base of tongue T4aN2cM0 chemo N NED
32 M 59 base of tongue T4N2bM0 chemo Y negative NED
33 M 72 base of tongue T2N2bM0 immuno N NED
*

DM: Distant Metastasis

**

NED: No Evidence of Disease

HHS Vulnerability Disclosure